.

Case Law Alerts

Patient Safety Privilege gets boost in Sanders.

Sanders v. Children’s Hospital of Philadelphia, 2022 Pa. Super. 199, 2022 WL 17099057 (Pa. Super. 2022)

January 1, 2023

Certain records, including investigation reports and PowerPoint slides, can be privileged under the Patient Safety Privilege if certain conditions apply. The Patient Safety Privilege, enumerated in the Medical Care Availability and Reduction of Error (MCARE) Act at 40 P.S. §1303.311, states that documents prepared for the purpose of compliance with section 40 P.S. §1303.310(b), regarding patient safety committee obligations, or reporting sections, such as 40 P.S. §1303.309(4), are privileged if the records also arise out of matters reviewed by a Patient Safety Committee and are otherwise not available from original sources. 

The Patient Safety Privilege was recently tested in Sanders, where there was an adenovirus outbreak in the NICU at the defendant hospital. Following the outbreak, the defendant tasked Dr. Sammons “to find the cause and stop the outbreak,” who reported to the defendant’s patient safety officer, Dr. Boswinkel. Plaintiffs in three separate suits sought discovery regarding the defendant’s investigation. The defendant asserted privilege, which the trial court overruled. The defendant appealed, and the three interlocutory appeals were consolidated before the Superior Court.

On appeal, the court examined numerous records developed during this investigation under the Patient Safety Privilege . The first record at issue was a root cause analysis report, which summarized the evaluation of the outbreak and proposed a plan to prevent recurrence. First, the court found that the report was prepared for compliance with 40 P.S. § 1303.309(4) concerning the duty of a patient safety officer to report to the Patient Safety Committee actions taken to promote patient safety. Second, the court found that the report was received by the Patient Safety Committee in compliance with §1303.310(b) regarding the duty of a Patient Safety Committee to receive and evaluate such reports. Therefore, the report was privileged because it was created for compliance with reporting sections of MCARE, and Patient Safety Committee’s obligations arose out of matters that were reviewed by the Patient Safety Committee and were otherwise not available from original sources. 

The second record at issue were PowerPoint slides utilized throughout the defendant’s investigation. First, the court found that the slides used during meetings and presentations with various departments, committees and personnel were used in fulfillment of Dr. Boswinkel’s duties as safety officer, including under §1303.309(4), to investigate all serious events and report actions taken thereto to the Patient Safety Committee. Second, the court found that the slides were used by the Patient Safety Committee to evaluate the outbreak response by infection prevention and NICU providers and next steps to prevent recurrence, in accordance with the duties of a Patient Safety Committee at §1303.310(b). Therefore, the PowerPoint slides were privileged as well. 

The final records at issue were blogs on the defendant’s intranet and ophthalmology emails regarding new policies resulting from the investigation. The court found that the Patient Safety Privilege did not apply as these records were reports from, not to, the Patient Safety Committee. 

The takeaway here is that certain records, including root cause reports and PowerPoint slides, can be confidential under the Patient Safety Privilege if the materials are: (1) solely prepared for the patient safety reporting sections of MCARE or Patient Safety Committee obligations, (2) arose out of matters reviewed by a Patient Safety Committee, and (3) not otherwise available from original sources. Additionally, a Patient Safety Committee needs to be cognizant of records they provide to their employees, as Sanders shows that these records are not protected. 
 

Case Law Alerts, 1st Quarter, January 2023 is prepared by Marshall Dennehey to provide information on recent developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. Copyright © 2032 Marshall Dennehey, all rights reserved. This article may not be reprinted without the express written permission of our firm.

Firm Highlights

Thought Leadership

Appellate Division Affirms Dismissal of Legal Malpractice Counterclaim Against Martin Law Firm

In Martin v. Loury, 2026 N.J. Super. Unpub. LEXIS 1617 (App. Div. July 15, 2026), Martin Law Firm represented Kirk Loury in an employment matter Mr. Loury filed against his former employer, Concord Equity Group Advisors LLC (“Concord”). The allegations included, among other things, that Loury was not fairly compensated for his employment with Concord. After a bench trial finding in Loury’s favor, the Appellate Division remanded this matter in February 2016 for a second trial. During the second trial, Concord CEO, Lee Argush, testified to lower compensation estimate than first trial. On remand, the second trial judge awarded Mr. Loury the same damages as the first judge, finding Mr. Argush not credible. After the findings during the second trial, Martin Law Firm filed an action against Mr. Loury to recover legal fees and costs of representing Mr. Loury in a second bench trial and Mr. Loury filed a counterclaim against Martin Law Firm for legal malpractice, alleging he should have received an even higher award in the second bench trial. In this allegation, Mr. Loury, through his expert, claimed that Martin Law Firm should have recalled Mr. Loury to the stand to rebut Mr. Argush’s testimony to allege an alternative theory of damages. Mr. Loury’s expert admitted that the second judge already rejected Mr. Argush's theory and accepted Loury's damages theory. The trial court barred Mr. Loury’s expert and dismissed Loury's counterclaim with prejudice before convening the collection trial, and the jury ruled in Martin Law Firm’s favor. Mr. Loury appealed the trial court's pretrial rulings barring his liability expert from testifying in support of his legal malpractice counterclaim, denying his motion for summary judgment on that counterclaim, and denying his motion to amend his counterclaim by adding attorney Joseph A. Martin as a codefendant. In affirming the trial court’s decision, the Appellate Division held that the trial court properly excluded Loury’s expert testimony in the counterclaim against Martin Law Firm because the expert could not explain how calling Loury as a rebuttal witness would have increased damages when the second judge already rejected Mr. Argush's testimony and accepted Loury's damages theory, making the expert’s causation opinion speculative. The Appellate Division also held that the trial court properly denied Mr. Loury's summary judgment motion on his malpractice counterclaim because reasonable minds could differ on whether Mr. Martin's alleged failures would have changed the second judge's damages award, given the judge already found Mr. Argush not credible, creating genuine factual disputes precluding summary judgment. Also, the Appellate Division held that the trial court properly denied Loury's May 2023 motion to add Joseph Martin individually because the statute of limitations expired in February 2022, six years after the 2016 appellate remand when Mr. Loury incurred new legal costs, and relation back did not apply because Mr. Loury knew Mr. Martin's identity throughout and strategically chose to sue only Martin Law Firm in his 2019 counterclaim.